nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Carmustine—melanoma	0.181	0.229	CbGbCtD
Cyclobenzaprine—CYP1A2—Vemurafenib—melanoma	0.143	0.181	CbGbCtD
Cyclobenzaprine—CYP3A4—Temozolomide—melanoma	0.137	0.173	CbGbCtD
Cyclobenzaprine—CYP2D6—Vemurafenib—melanoma	0.118	0.149	CbGbCtD
Cyclobenzaprine—CYP1A2—Dacarbazine—melanoma	0.11	0.139	CbGbCtD
Cyclobenzaprine—CYP3A4—Vemurafenib—melanoma	0.0751	0.095	CbGbCtD
Cyclobenzaprine—CYP3A4—Docetaxel—melanoma	0.0258	0.0326	CbGbCtD
Cyclobenzaprine—Olopatadine—S100B—melanoma	0.00301	0.544	CrCbGaD
Cyclobenzaprine—Thinking abnormal—Carmustine—melanoma	0.00165	0.0093	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Vemurafenib—melanoma	0.00157	0.00883	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Carmustine—melanoma	0.00155	0.00873	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Carmustine—melanoma	0.00154	0.00867	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Temozolomide—melanoma	0.0015	0.00843	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Temozolomide—melanoma	0.00149	0.00838	CcSEcCtD
Cyclobenzaprine—Disorientation—Bleomycin—melanoma	0.00141	0.00792	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Carmustine—melanoma	0.00135	0.00762	CcSEcCtD
Cyclobenzaprine—Mental disability—Carmustine—melanoma	0.00131	0.00739	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Bleomycin—melanoma	0.00128	0.00723	CcSEcCtD
Cyclobenzaprine—Alopecia—Vemurafenib—melanoma	0.00127	0.00715	CcSEcCtD
Cyclobenzaprine—Mental disability—Temozolomide—melanoma	0.00127	0.00714	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Vemurafenib—melanoma	0.00122	0.00689	CcSEcCtD
Cyclobenzaprine—Ageusia—Docetaxel—melanoma	0.0012	0.00676	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Temozolomide—melanoma	0.00119	0.00668	CcSEcCtD
Cyclobenzaprine—Thirst—Temozolomide—melanoma	0.00111	0.00628	CcSEcCtD
Cyclobenzaprine—Purpura—Temozolomide—melanoma	0.0011	0.0062	CcSEcCtD
Cyclobenzaprine—Diplopia—Carmustine—melanoma	0.0011	0.00618	CcSEcCtD
Cyclobenzaprine—Myalgia—Vemurafenib—melanoma	0.00106	0.00599	CcSEcCtD
Cyclobenzaprine—Diplopia—Temozolomide—melanoma	0.00106	0.00597	CcSEcCtD
Cyclobenzaprine—Face oedema—Carmustine—melanoma	0.00106	0.00597	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Bleomycin—melanoma	0.00103	0.00581	CcSEcCtD
Cyclobenzaprine—Ataxia—Carmustine—melanoma	0.00103	0.00581	CcSEcCtD
Cyclobenzaprine—Face oedema—Temozolomide—melanoma	0.00102	0.00577	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Vemurafenib—melanoma	0.00102	0.00575	CcSEcCtD
Cyclobenzaprine—Ataxia—Temozolomide—melanoma	0.000997	0.00562	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Dactinomycin—melanoma	0.000962	0.00542	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Bleomycin—melanoma	0.000955	0.00538	CcSEcCtD
Cyclobenzaprine—Hypotension—Vemurafenib—melanoma	0.000953	0.00537	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Bleomycin—melanoma	0.00095	0.00535	CcSEcCtD
Cyclobenzaprine—Stomatitis—Bleomycin—melanoma	0.000944	0.00532	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000929	0.00523	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Carmustine—melanoma	0.000901	0.00507	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vemurafenib—melanoma	0.000887	0.00499	CcSEcCtD
Cyclobenzaprine—Stomatitis—Dactinomycin—melanoma	0.000881	0.00496	CcSEcCtD
Cyclobenzaprine—Fatigue—Vemurafenib—melanoma	0.000879	0.00495	CcSEcCtD
Cyclobenzaprine—Constipation—Vemurafenib—melanoma	0.000872	0.00491	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Temozolomide—melanoma	0.000871	0.0049	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Bleomycin—melanoma	0.000865	0.00487	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Temozolomide—melanoma	0.000852	0.0048	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Temozolomide—melanoma	0.000847	0.00477	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Temozolomide—melanoma	0.000844	0.00476	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Dactinomycin—melanoma	0.000843	0.00475	CcSEcCtD
Cyclobenzaprine—Weight increased—Temozolomide—melanoma	0.000834	0.0047	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Carmustine—melanoma	0.000829	0.00467	CcSEcCtD
Cyclobenzaprine—Stomatitis—Carmustine—melanoma	0.000824	0.00464	CcSEcCtD
Cyclobenzaprine—Hepatitis—Dactinomycin—melanoma	0.000811	0.00457	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Dactinomycin—melanoma	0.000805	0.00454	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Temozolomide—melanoma	0.000801	0.00451	CcSEcCtD
Cyclobenzaprine—Stomatitis—Temozolomide—melanoma	0.000797	0.00449	CcSEcCtD
Cyclobenzaprine—Alopecia—Bleomycin—melanoma	0.000769	0.00433	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Carmustine—melanoma	0.000755	0.00426	CcSEcCtD
Cyclobenzaprine—Hallucination—Carmustine—melanoma	0.000755	0.00426	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vemurafenib—melanoma	0.000751	0.00423	CcSEcCtD
Cyclobenzaprine—Hepatitis—Temozolomide—melanoma	0.000734	0.00413	CcSEcCtD
Cyclobenzaprine—Asthenia—Vemurafenib—melanoma	0.000732	0.00412	CcSEcCtD
Cyclobenzaprine—Hallucination—Temozolomide—melanoma	0.00073	0.00411	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Temozolomide—melanoma	0.00073	0.00411	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Temozolomide—melanoma	0.000728	0.0041	CcSEcCtD
Cyclobenzaprine—Pruritus—Vemurafenib—melanoma	0.000722	0.00406	CcSEcCtD
Cyclobenzaprine—Alopecia—Dactinomycin—melanoma	0.000717	0.00404	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Bleomycin—melanoma	0.000703	0.00396	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vemurafenib—melanoma	0.000698	0.00393	CcSEcCtD
Cyclobenzaprine—Tinnitus—Temozolomide—melanoma	0.000684	0.00385	CcSEcCtD
Cyclobenzaprine—Malaise—Bleomycin—melanoma	0.000683	0.00385	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Carmustine—melanoma	0.000678	0.00382	CcSEcCtD
Cyclobenzaprine—Leukopenia—Bleomycin—melanoma	0.000678	0.00382	CcSEcCtD
Cyclobenzaprine—Dizziness—Vemurafenib—melanoma	0.000674	0.0038	CcSEcCtD
Cyclobenzaprine—Alopecia—Carmustine—melanoma	0.000671	0.00378	CcSEcCtD
Cyclobenzaprine—Ataxia—Docetaxel—melanoma	0.000663	0.00374	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Dactinomycin—melanoma	0.000655	0.00369	CcSEcCtD
Cyclobenzaprine—Vomiting—Vemurafenib—melanoma	0.000649	0.00365	CcSEcCtD
Cyclobenzaprine—Alopecia—Temozolomide—melanoma	0.000648	0.00365	CcSEcCtD
Cyclobenzaprine—Myalgia—Bleomycin—melanoma	0.000645	0.00363	CcSEcCtD
Cyclobenzaprine—Chest pain—Bleomycin—melanoma	0.000645	0.00363	CcSEcCtD
Cyclobenzaprine—Rash—Vemurafenib—melanoma	0.000643	0.00362	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vemurafenib—melanoma	0.000643	0.00362	CcSEcCtD
Cyclobenzaprine—Headache—Vemurafenib—melanoma	0.000639	0.0036	CcSEcCtD
Cyclobenzaprine—Discomfort—Bleomycin—melanoma	0.000637	0.00359	CcSEcCtD
Cyclobenzaprine—Malaise—Dactinomycin—melanoma	0.000637	0.00359	CcSEcCtD
Cyclobenzaprine—Leukopenia—Dactinomycin—melanoma	0.000632	0.00356	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Temozolomide—melanoma	0.000625	0.00352	CcSEcCtD
Cyclobenzaprine—Confusional state—Bleomycin—melanoma	0.000623	0.00351	CcSEcCtD
Cyclobenzaprine—Vision blurred—Carmustine—melanoma	0.000623	0.00351	CcSEcCtD
Cyclobenzaprine—Tremor—Carmustine—melanoma	0.000619	0.00349	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Bleomycin—melanoma	0.000618	0.00348	CcSEcCtD
Cyclobenzaprine—Oedema—Bleomycin—melanoma	0.000618	0.00348	CcSEcCtD
Cyclobenzaprine—Agitation—Carmustine—melanoma	0.000607	0.00342	CcSEcCtD
Cyclobenzaprine—Nausea—Vemurafenib—melanoma	0.000606	0.00341	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Bleomycin—melanoma	0.000605	0.00341	CcSEcCtD
Cyclobenzaprine—Vision blurred—Temozolomide—melanoma	0.000602	0.00339	CcSEcCtD
Cyclobenzaprine—Myalgia—Dactinomycin—melanoma	0.000601	0.00339	CcSEcCtD
Cyclobenzaprine—Tremor—Temozolomide—melanoma	0.000598	0.00337	CcSEcCtD
Cyclobenzaprine—Discomfort—Dactinomycin—melanoma	0.000594	0.00335	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Temozolomide—melanoma	0.000593	0.00334	CcSEcCtD
Cyclobenzaprine—Leukopenia—Carmustine—melanoma	0.000592	0.00333	CcSEcCtD
Cyclobenzaprine—Anorexia—Bleomycin—melanoma	0.000589	0.00332	CcSEcCtD
Cyclobenzaprine—Agitation—Temozolomide—melanoma	0.000587	0.00331	CcSEcCtD
Cyclobenzaprine—Angioedema—Temozolomide—melanoma	0.000584	0.00329	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Docetaxel—melanoma	0.000579	0.00326	CcSEcCtD
Cyclobenzaprine—Hypotension—Bleomycin—melanoma	0.000577	0.00325	CcSEcCtD
Cyclobenzaprine—Oedema—Dactinomycin—melanoma	0.000576	0.00325	CcSEcCtD
Cyclobenzaprine—Malaise—Temozolomide—melanoma	0.000576	0.00324	CcSEcCtD
Cyclobenzaprine—Vertigo—Temozolomide—melanoma	0.000574	0.00323	CcSEcCtD
Cyclobenzaprine—Convulsion—Carmustine—melanoma	0.000573	0.00323	CcSEcCtD
Cyclobenzaprine—Leukopenia—Temozolomide—melanoma	0.000572	0.00322	CcSEcCtD
Cyclobenzaprine—Hypertension—Carmustine—melanoma	0.000571	0.00321	CcSEcCtD
Cyclobenzaprine—Palpitations—Temozolomide—melanoma	0.000564	0.00318	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dactinomycin—melanoma	0.000564	0.00318	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000563	0.00317	CcSEcCtD
Cyclobenzaprine—Chest pain—Carmustine—melanoma	0.000563	0.00317	CcSEcCtD
Cyclobenzaprine—Myalgia—Carmustine—melanoma	0.000563	0.00317	CcSEcCtD
Cyclobenzaprine—Anxiety—Carmustine—melanoma	0.000561	0.00316	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Bleomycin—melanoma	0.000555	0.00313	CcSEcCtD
Cyclobenzaprine—Weight increased—Docetaxel—melanoma	0.000555	0.00312	CcSEcCtD
Cyclobenzaprine—Convulsion—Temozolomide—melanoma	0.000553	0.00312	CcSEcCtD
Cyclobenzaprine—Hypertension—Temozolomide—melanoma	0.000551	0.00311	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Bleomycin—melanoma	0.000551	0.0031	CcSEcCtD
Cyclobenzaprine—Anorexia—Dactinomycin—melanoma	0.000549	0.00309	CcSEcCtD
Cyclobenzaprine—Confusional state—Carmustine—melanoma	0.000544	0.00306	CcSEcCtD
Cyclobenzaprine—Myalgia—Temozolomide—melanoma	0.000544	0.00306	CcSEcCtD
Cyclobenzaprine—Anxiety—Temozolomide—melanoma	0.000542	0.00305	CcSEcCtD
Cyclobenzaprine—Oedema—Carmustine—melanoma	0.000539	0.00304	CcSEcCtD
Cyclobenzaprine—Discomfort—Temozolomide—melanoma	0.000537	0.00303	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Bleomycin—melanoma	0.000537	0.00303	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Docetaxel—melanoma	0.000536	0.00302	CcSEcCtD
Cyclobenzaprine—Orphenadrine—SCN10A—melanoma	0.000535	0.0967	CrCbGaD
Cyclobenzaprine—Myocardial infarction—Docetaxel—melanoma	0.000533	0.003	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Docetaxel—melanoma	0.000533	0.003	CcSEcCtD
Cyclobenzaprine—Dry mouth—Temozolomide—melanoma	0.000532	0.003	CcSEcCtD
Cyclobenzaprine—Jaundice—Docetaxel—melanoma	0.00053	0.00298	CcSEcCtD
Cyclobenzaprine—Stomatitis—Docetaxel—melanoma	0.00053	0.00298	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Carmustine—melanoma	0.000528	0.00297	CcSEcCtD
Cyclobenzaprine—Tachycardia—Carmustine—melanoma	0.000526	0.00297	CcSEcCtD
Cyclobenzaprine—Confusional state—Temozolomide—melanoma	0.000526	0.00296	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000525	0.00296	CcSEcCtD
Cyclobenzaprine—Oedema—Temozolomide—melanoma	0.000521	0.00294	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Temozolomide—melanoma	0.000521	0.00294	CcSEcCtD
Cyclobenzaprine—Anorexia—Carmustine—melanoma	0.000514	0.0029	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Temozolomide—melanoma	0.00051	0.00287	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Bleomycin—melanoma	0.000509	0.00287	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Docetaxel—melanoma	0.000507	0.00286	CcSEcCtD
Cyclobenzaprine—Hypotension—Carmustine—melanoma	0.000504	0.00284	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Temozolomide—melanoma	0.000504	0.00284	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dactinomycin—melanoma	0.000501	0.00282	CcSEcCtD
Cyclobenzaprine—Fatigue—Dactinomycin—melanoma	0.000497	0.0028	CcSEcCtD
Cyclobenzaprine—Anorexia—Temozolomide—melanoma	0.000497	0.0028	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Carmustine—melanoma	0.000491	0.00277	CcSEcCtD
Cyclobenzaprine—Urticaria—Bleomycin—melanoma	0.000491	0.00277	CcSEcCtD
Cyclobenzaprine—Hepatitis—Docetaxel—melanoma	0.000488	0.00275	CcSEcCtD
Cyclobenzaprine—Insomnia—Carmustine—melanoma	0.000488	0.00275	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Docetaxel—melanoma	0.000485	0.00273	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Carmustine—melanoma	0.000484	0.00273	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Docetaxel—melanoma	0.000484	0.00273	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Carmustine—melanoma	0.000481	0.00271	CcSEcCtD
Cyclobenzaprine—Somnolence—Carmustine—melanoma	0.00048	0.0027	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dactinomycin—melanoma	0.000475	0.00268	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000475	0.00268	CcSEcCtD
Cyclobenzaprine—Insomnia—Temozolomide—melanoma	0.000471	0.00266	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dactinomycin—melanoma	0.000471	0.00265	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Carmustine—melanoma	0.000469	0.00264	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Temozolomide—melanoma	0.000468	0.00264	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Temozolomide—melanoma	0.000465	0.00262	CcSEcCtD
Cyclobenzaprine—Somnolence—Temozolomide—melanoma	0.000463	0.00261	CcSEcCtD
Cyclobenzaprine—Constipation—Carmustine—melanoma	0.000461	0.0026	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Temozolomide—melanoma	0.000459	0.00258	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dactinomycin—melanoma	0.000456	0.00257	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Bleomycin—melanoma	0.000455	0.00256	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Temozolomide—melanoma	0.000453	0.00255	CcSEcCtD
Cyclobenzaprine—Fatigue—Temozolomide—melanoma	0.000449	0.00253	CcSEcCtD
Cyclobenzaprine—Constipation—Temozolomide—melanoma	0.000446	0.00251	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Carmustine—melanoma	0.000445	0.0025	CcSEcCtD
Cyclobenzaprine—Asthenia—Bleomycin—melanoma	0.000443	0.0025	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Carmustine—melanoma	0.000441	0.00248	CcSEcCtD
Cyclobenzaprine—Pruritus—Bleomycin—melanoma	0.000437	0.00246	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Docetaxel—melanoma	0.000436	0.00246	CcSEcCtD
Cyclobenzaprine—Alopecia—Docetaxel—melanoma	0.000431	0.00243	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Temozolomide—melanoma	0.00043	0.00242	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Carmustine—melanoma	0.000426	0.0024	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Temozolomide—melanoma	0.000426	0.0024	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—melanoma	0.000425	0.00239	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP1B1—melanoma	0.000421	0.0761	CrCbGaD
Cyclobenzaprine—Dysgeusia—Docetaxel—melanoma	0.000416	0.00234	CcSEcCtD
Cyclobenzaprine—Urticaria—Temozolomide—melanoma	0.000414	0.00233	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—melanoma	0.000414	0.00233	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Temozolomide—melanoma	0.000412	0.00232	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Carmustine—melanoma	0.000397	0.00224	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—melanoma	0.000394	0.00222	CcSEcCtD
Cyclobenzaprine—Vomiting—Bleomycin—melanoma	0.000393	0.00221	CcSEcCtD
Cyclobenzaprine—Rash—Bleomycin—melanoma	0.00039	0.00219	CcSEcCtD
Cyclobenzaprine—Dermatitis—Bleomycin—melanoma	0.000389	0.00219	CcSEcCtD
Cyclobenzaprine—Asthenia—Carmustine—melanoma	0.000387	0.00218	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Temozolomide—melanoma	0.000384	0.00216	CcSEcCtD
Cyclobenzaprine—Syncope—Docetaxel—melanoma	0.000381	0.00215	CcSEcCtD
Cyclobenzaprine—Leukopenia—Docetaxel—melanoma	0.00038	0.00214	CcSEcCtD
Cyclobenzaprine—Palpitations—Docetaxel—melanoma	0.000375	0.00211	CcSEcCtD
Cyclobenzaprine—Asthenia—Temozolomide—melanoma	0.000374	0.00211	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Docetaxel—melanoma	0.000373	0.0021	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Carmustine—melanoma	0.000369	0.00208	CcSEcCtD
Cyclobenzaprine—Pruritus—Temozolomide—melanoma	0.000369	0.00208	CcSEcCtD
Cyclobenzaprine—Convulsion—Docetaxel—melanoma	0.000368	0.00207	CcSEcCtD
Cyclobenzaprine—Nausea—Bleomycin—melanoma	0.000367	0.00207	CcSEcCtD
Cyclobenzaprine—Hypertension—Docetaxel—melanoma	0.000367	0.00207	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—melanoma	0.000366	0.00206	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—melanoma	0.000363	0.00205	CcSEcCtD
Cyclobenzaprine—Chest pain—Docetaxel—melanoma	0.000362	0.00204	CcSEcCtD
Cyclobenzaprine—Myalgia—Docetaxel—melanoma	0.000362	0.00204	CcSEcCtD
Cyclobenzaprine—Dizziness—Carmustine—melanoma	0.000357	0.00201	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Temozolomide—melanoma	0.000357	0.00201	CcSEcCtD
Cyclobenzaprine—Dry mouth—Docetaxel—melanoma	0.000354	0.00199	CcSEcCtD
Cyclobenzaprine—Protriptyline—ABCB1—melanoma	0.00035	0.0633	CrCbGaD
Cyclobenzaprine—Confusional state—Docetaxel—melanoma	0.00035	0.00197	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Docetaxel—melanoma	0.000347	0.00195	CcSEcCtD
Cyclobenzaprine—Oedema—Docetaxel—melanoma	0.000347	0.00195	CcSEcCtD
Cyclobenzaprine—Dizziness—Temozolomide—melanoma	0.000345	0.00194	CcSEcCtD
Cyclobenzaprine—Vomiting—Carmustine—melanoma	0.000343	0.00193	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—melanoma	0.000342	0.00193	CcSEcCtD
Cyclobenzaprine—Shock—Docetaxel—melanoma	0.000341	0.00192	CcSEcCtD
Cyclobenzaprine—Rash—Carmustine—melanoma	0.00034	0.00192	CcSEcCtD
Cyclobenzaprine—Dermatitis—Carmustine—melanoma	0.00034	0.00191	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Docetaxel—melanoma	0.000339	0.00191	CcSEcCtD
Cyclobenzaprine—Tachycardia—Docetaxel—melanoma	0.000338	0.00191	CcSEcCtD
Cyclobenzaprine—Headache—Carmustine—melanoma	0.000338	0.0019	CcSEcCtD
Cyclobenzaprine—Vomiting—Temozolomide—melanoma	0.000331	0.00187	CcSEcCtD
Cyclobenzaprine—Anorexia—Docetaxel—melanoma	0.00033	0.00186	CcSEcCtD
Cyclobenzaprine—Rash—Temozolomide—melanoma	0.000329	0.00185	CcSEcCtD
Cyclobenzaprine—Dermatitis—Temozolomide—melanoma	0.000328	0.00185	CcSEcCtD
Cyclobenzaprine—Headache—Temozolomide—melanoma	0.000327	0.00184	CcSEcCtD
Cyclobenzaprine—Hypotension—Docetaxel—melanoma	0.000324	0.00182	CcSEcCtD
Cyclobenzaprine—Nausea—Carmustine—melanoma	0.00032	0.0018	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000316	0.00178	CcSEcCtD
Cyclobenzaprine—Insomnia—Docetaxel—melanoma	0.000314	0.00177	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Docetaxel—melanoma	0.000311	0.00175	CcSEcCtD
Cyclobenzaprine—Nausea—Temozolomide—melanoma	0.00031	0.00174	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Docetaxel—melanoma	0.000309	0.00174	CcSEcCtD
Cyclobenzaprine—Somnolence—Docetaxel—melanoma	0.000308	0.00174	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Docetaxel—melanoma	0.000305	0.00172	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Docetaxel—melanoma	0.000301	0.0017	CcSEcCtD
Cyclobenzaprine—Fatigue—Docetaxel—melanoma	0.000299	0.00168	CcSEcCtD
Cyclobenzaprine—Constipation—Docetaxel—melanoma	0.000296	0.00167	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Docetaxel—melanoma	0.000286	0.00161	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Docetaxel—melanoma	0.000283	0.0016	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Docetaxel—melanoma	0.000274	0.00154	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Docetaxel—melanoma	0.000255	0.00144	CcSEcCtD
Cyclobenzaprine—Asthenia—Docetaxel—melanoma	0.000249	0.0014	CcSEcCtD
Cyclobenzaprine—Pruritus—Docetaxel—melanoma	0.000245	0.00138	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Docetaxel—melanoma	0.000237	0.00134	CcSEcCtD
Cyclobenzaprine—Dizziness—Docetaxel—melanoma	0.000229	0.00129	CcSEcCtD
Cyclobenzaprine—Vomiting—Docetaxel—melanoma	0.00022	0.00124	CcSEcCtD
Cyclobenzaprine—Rash—Docetaxel—melanoma	0.000219	0.00123	CcSEcCtD
Cyclobenzaprine—Dermatitis—Docetaxel—melanoma	0.000218	0.00123	CcSEcCtD
Cyclobenzaprine—Headache—Docetaxel—melanoma	0.000217	0.00122	CcSEcCtD
Cyclobenzaprine—Nausea—Docetaxel—melanoma	0.000206	0.00116	CcSEcCtD
Cyclobenzaprine—Carbamazepine—ABCB1—melanoma	0.000163	0.0295	CrCbGaD
Cyclobenzaprine—Nortriptyline—ALB—melanoma	0.000141	0.0254	CrCbGaD
Cyclobenzaprine—Chlorprothixene—ABCB1—melanoma	0.000137	0.0247	CrCbGaD
Cyclobenzaprine—Trimipramine—ABCB1—melanoma	0.000126	0.0228	CrCbGaD
Cyclobenzaprine—Promethazine—ABCB1—melanoma	0.000122	0.022	CrCbGaD
Cyclobenzaprine—Tamoxifen—ABCB1—melanoma	0.000121	0.0218	CrCbGaD
Cyclobenzaprine—Doxepin—ABCB1—melanoma	0.00012	0.0218	CrCbGaD
Cyclobenzaprine—Amitriptyline—ALB—melanoma	9.76e-05	0.0176	CrCbGaD
Cyclobenzaprine—Imipramine—ABCB1—melanoma	9.38e-05	0.0169	CrCbGaD
Cyclobenzaprine—Amitriptyline—ABCB1—melanoma	9.32e-05	0.0168	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDNRB—melanoma	2.11e-05	0.000809	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM3—melanoma	2.1e-05	0.000808	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HS3ST5—melanoma	2.09e-05	0.000801	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCR4—melanoma	2.06e-05	0.000791	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	2.06e-05	0.000791	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GNAQ—melanoma	2.04e-05	0.000782	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KISS1—melanoma	2e-05	0.000766	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GNA11—melanoma	1.99e-05	0.000764	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GAB2—melanoma	1.99e-05	0.000764	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	1.98e-05	0.000762	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	1.96e-05	0.000752	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	1.96e-05	0.000752	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—melanoma	1.95e-05	0.000747	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCR1—melanoma	1.93e-05	0.000742	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SKI—melanoma	1.93e-05	0.000742	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MC1R—melanoma	1.9e-05	0.000731	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—PIK3CA—melanoma	1.9e-05	0.00073	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACER3—melanoma	1.89e-05	0.000727	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT3—melanoma	1.88e-05	0.000722	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCR4—melanoma	1.87e-05	0.000719	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLCB4—melanoma	1.87e-05	0.000717	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GNAQ—melanoma	1.85e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	1.85e-05	0.00071	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM1—melanoma	1.82e-05	0.000701	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCR7—melanoma	1.82e-05	0.000701	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SUFU—melanoma	1.78e-05	0.000683	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC6A11—melanoma	1.75e-05	0.000674	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIP4K2A—melanoma	1.75e-05	0.000674	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—UGT2B10—melanoma	1.73e-05	0.000665	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT3—melanoma	1.71e-05	0.000656	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTAP—melanoma	1.71e-05	0.000655	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	1.7e-05	0.000653	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.68e-05	0.000645	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RHOB—melanoma	1.66e-05	0.000637	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BCL2L11—melanoma	1.66e-05	0.000637	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HS3ST5—melanoma	1.61e-05	0.000618	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HDAC6—melanoma	1.59e-05	0.000612	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLCB4—melanoma	1.58e-05	0.000607	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—EDN1—melanoma	1.58e-05	0.000607	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	1.57e-05	0.000604	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	1.55e-05	0.000596	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CSF2—melanoma	1.54e-05	0.000593	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PHGDH—melanoma	1.52e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LUM—melanoma	1.52e-05	0.000584	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCR2—melanoma	1.51e-05	0.000581	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—CXCL8—melanoma	1.51e-05	0.00058	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	1.51e-05	0.000578	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HPSE—melanoma	1.49e-05	0.000573	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAC2—melanoma	1.49e-05	0.000571	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIP4K2A—melanoma	1.49e-05	0.000571	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC6A11—melanoma	1.49e-05	0.000571	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PRKCA—melanoma	1.48e-05	0.000568	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CUBN—melanoma	1.46e-05	0.000562	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFC—melanoma	1.46e-05	0.000562	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—WNT5A—melanoma	1.46e-05	0.000562	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTAP—melanoma	1.45e-05	0.000555	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDN1—melanoma	1.43e-05	0.000551	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BSG—melanoma	1.41e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CSPG4—melanoma	1.41e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SDHD—melanoma	1.41e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	1.41e-05	0.000543	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CSF2—melanoma	1.4e-05	0.000538	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—RAC1—melanoma	1.37e-05	0.000527	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPAM—melanoma	1.37e-05	0.000526	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PRKCA—melanoma	1.34e-05	0.000516	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAP2K2—melanoma	1.31e-05	0.000505	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LUM—melanoma	1.29e-05	0.000495	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PHGDH—melanoma	1.29e-05	0.000495	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—F2R—melanoma	1.29e-05	0.000494	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HPSE—melanoma	1.26e-05	0.000485	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RAC1—melanoma	1.25e-05	0.000479	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDNRB—melanoma	1.25e-05	0.000478	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CUBN—melanoma	1.24e-05	0.000476	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLCB4—melanoma	1.22e-05	0.000469	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTK2B—melanoma	1.21e-05	0.000464	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BSG—melanoma	1.2e-05	0.00046	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SDHD—melanoma	1.2e-05	0.00046	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CSPG4—melanoma	1.2e-05	0.00046	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GAB2—melanoma	1.18e-05	0.000451	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNA11—melanoma	1.18e-05	0.000451	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FLT1—melanoma	1.17e-05	0.000449	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLA2G6—melanoma	1.16e-05	0.000447	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPAM—melanoma	1.16e-05	0.000446	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CG—melanoma	1.16e-05	0.000445	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC6A11—melanoma	1.15e-05	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.15e-05	0.00044	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTAP—melanoma	1.12e-05	0.000429	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HDAC2—melanoma	1.11e-05	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FOXO4—melanoma	1.11e-05	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCR4—melanoma	1.11e-05	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GNAQ—melanoma	1.09e-05	0.00042	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CG—melanoma	1.05e-05	0.000404	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—VCAN—melanoma	1.05e-05	0.000402	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SYK—melanoma	1.03e-05	0.000395	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CD—melanoma	1.02e-05	0.000391	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT3—melanoma	1.01e-05	0.000387	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ITGAV—melanoma	1.01e-05	0.000387	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGFR—melanoma	1.01e-05	0.000387	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PHGDH—melanoma	9.95e-06	0.000382	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LUM—melanoma	9.95e-06	0.000382	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G6—melanoma	9.87e-06	0.000379	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HPSE—melanoma	9.76e-06	0.000375	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CUBN—melanoma	9.58e-06	0.000368	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SOCS1—melanoma	9.34e-06	0.000359	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAP2K1—melanoma	9.32e-06	0.000358	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—S100B—melanoma	9.32e-06	0.000358	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CD—melanoma	9.26e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SDHD—melanoma	9.25e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CSPG4—melanoma	9.25e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BSG—melanoma	9.25e-06	0.000355	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPAM—melanoma	8.96e-06	0.000344	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB4—melanoma	8.91e-06	0.000342	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CB—melanoma	8.89e-06	0.000341	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—VCAN—melanoma	8.86e-06	0.00034	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN2B—melanoma	8.83e-06	0.000339	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP17A1—melanoma	8.83e-06	0.000339	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CD86—melanoma	8.54e-06	0.000328	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—CXCL8—melanoma	8.54e-06	0.000328	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—melanoma	8.48e-06	0.000325	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.39e-06	0.000322	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GNA11—melanoma	8.34e-06	0.00032	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF1—melanoma	8.28e-06	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CSF2—melanoma	8.28e-06	0.000318	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—IL2—melanoma	8.16e-06	0.000313	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FASN—melanoma	8.16e-06	0.000313	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—E2F1—melanoma	8.11e-06	0.000311	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.1e-06	0.000311	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CB—melanoma	8.07e-06	0.00031	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC5A5—melanoma	8.02e-06	0.000308	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDGFRA—melanoma	8.02e-06	0.000308	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ITGB3—melanoma	7.94e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PRKCA—melanoma	7.94e-06	0.000305	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SPP1—melanoma	7.79e-06	0.000299	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAP2K2—melanoma	7.76e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—CXCL8—melanoma	7.75e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GNAQ—melanoma	7.75e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CD44—melanoma	7.75e-06	0.000298	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G6—melanoma	7.62e-06	0.000292	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP17A1—melanoma	7.48e-06	0.000287	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1B1—melanoma	7.43e-06	0.000285	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL2—melanoma	7.41e-06	0.000285	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TERT—melanoma	7.38e-06	0.000283	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.38e-06	0.000283	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAC1—melanoma	7.36e-06	0.000283	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	7.28e-06	0.00028	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GNA11—melanoma	7.06e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIF1A—melanoma	7.06e-06	0.000271	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FASN—melanoma	6.91e-06	0.000265	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—VCAN—melanoma	6.84e-06	0.000263	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC5A5—melanoma	6.8e-06	0.000261	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KDR—melanoma	6.75e-06	0.000259	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GNAQ—melanoma	6.57e-06	0.000252	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CD44—melanoma	6.57e-06	0.000252	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FN1—melanoma	6.5e-06	0.00025	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.43e-06	0.000247	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.37e-06	0.000245	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NOTCH1—melanoma	6.36e-06	0.000244	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP1B1—melanoma	6.29e-06	0.000242	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CD80—melanoma	6.23e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APC—melanoma	6.22e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KIT—melanoma	6.22e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CG—melanoma	6.22e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—NRAS—melanoma	6.22e-06	0.000239	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGF—melanoma	6.15e-06	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCB1—melanoma	6.12e-06	0.000235	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK3—melanoma	5.96e-06	0.000229	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BRAF—melanoma	5.85e-06	0.000225	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP17A1—melanoma	5.77e-06	0.000222	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1—melanoma	5.7e-06	0.000219	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK1—melanoma	5.67e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EGFR—melanoma	5.67e-06	0.000218	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PRKCA—melanoma	5.63e-06	0.000216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ERCC2—melanoma	5.59e-06	0.000214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.56e-06	0.000213	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAP2K1—melanoma	5.51e-06	0.000211	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CD—melanoma	5.47e-06	0.00021	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GNA11—melanoma	5.45e-06	0.000209	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	5.42e-06	0.000208	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KRAS—melanoma	5.35e-06	0.000206	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FASN—melanoma	5.33e-06	0.000205	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A5—melanoma	5.25e-06	0.000201	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF2—melanoma	5.24e-06	0.000201	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCB1—melanoma	5.18e-06	0.000199	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GNAQ—melanoma	5.07e-06	0.000195	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CD44—melanoma	5.07e-06	0.000195	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CA—melanoma	4.92e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MDM2—melanoma	4.9e-06	0.000188	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1B1—melanoma	4.86e-06	0.000187	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB2—melanoma	4.83e-06	0.000185	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PRKCA—melanoma	4.77e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CB—melanoma	4.77e-06	0.000183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ERCC2—melanoma	4.73e-06	0.000182	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CXCL8—melanoma	4.58e-06	0.000176	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HRAS—melanoma	4.55e-06	0.000175	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN1B—melanoma	4.47e-06	0.000172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKT1—melanoma	4.43e-06	0.00017	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CG—melanoma	4.41e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—melanoma	4.38e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL2—melanoma	4.38e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—melanoma	4.36e-06	0.000167	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCND1—melanoma	4.27e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPARG—melanoma	4.26e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CTNNB1—melanoma	4.23e-06	0.000162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MMP9—melanoma	4.14e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN1A—melanoma	4.13e-06	0.000159	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTEN—melanoma	4.12e-06	0.000158	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NFKB1—melanoma	4.1e-06	0.000157	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKT1—melanoma	4.02e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCB1—melanoma	4e-06	0.000154	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.92e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CD—melanoma	3.88e-06	0.000149	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALB—melanoma	3.83e-06	0.000147	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CG—melanoma	3.74e-06	0.000143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—melanoma	3.72e-06	0.000143	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—STAT3—melanoma	3.68e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PRKCA—melanoma	3.68e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NRAS—melanoma	3.68e-06	0.000141	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ERCC2—melanoma	3.65e-06	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPARG—melanoma	3.61e-06	0.000138	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK3—melanoma	3.52e-06	0.000135	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MYC—melanoma	3.42e-06	0.000131	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CB—melanoma	3.38e-06	0.00013	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK1—melanoma	3.35e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—melanoma	3.35e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EGFR—melanoma	3.35e-06	0.000129	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CD—melanoma	3.28e-06	0.000126	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALB—melanoma	3.24e-06	0.000125	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KRAS—melanoma	3.16e-06	0.000121	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTEN—melanoma	2.92e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.91e-06	0.000112	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CG—melanoma	2.88e-06	0.000111	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CB—melanoma	2.86e-06	0.00011	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—melanoma	2.84e-06	0.000109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—melanoma	2.81e-06	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPARG—melanoma	2.78e-06	0.000107	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HRAS—melanoma	2.69e-06	0.000103	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—melanoma	2.57e-06	9.88e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CD—melanoma	2.54e-06	9.73e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALB—melanoma	2.5e-06	9.61e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTEN—melanoma	2.47e-06	9.5e-05	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKT1—melanoma	2.37e-06	9.11e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CB—melanoma	2.21e-06	8.48e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—melanoma	2.19e-06	8.41e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CA—melanoma	2.06e-06	7.91e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTEN—melanoma	1.91e-06	7.33e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CA—melanoma	1.75e-06	6.7e-05	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—AKT1—melanoma	1.68e-06	6.46e-05	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—AKT1—melanoma	1.43e-06	5.47e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CA—melanoma	1.35e-06	5.17e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—AKT1—melanoma	1.1e-06	4.22e-05	CbGpPWpGaD
